P innovation’s new, generic next-generation dry powder inhaler (DPI) filling technology has become available on the market.

The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...

During the run-in, all subjects were required to stop their inhaled corticosteroid and long-acting β 2-agonist if appropriate and take Seretide™ one inhalation twice daily from a Diskus ...

A full five years after the coronavirus pandemic began, millions are struggling with long COVID symptoms so varied that there ...

which came off patent in 2010 [although integration as part of the Diskus delivery device extended the patent life until 2016]. To ensure that an inhalation device is effective, it must be matched ...

Serevent Diskus) or twisting base (e.g., Pulmicort Flexhaler, Asmanex Twisthaler). • Wash single-dose dry powder inhaler device (in warm water) once weekly and air dry. • Do not expose ...

The two inhaled treatments — Flovent HFA and Flovent Diskus, two of the most commonly ... The medication may be a different dose or a different inhaler device from what you are used to ...

He was told the price of the inhaler had increased from $66 to $539 ... which allows them to offer prescription drugs at a reduced rate. Advair Diskus, the medication Cole required to treat ...

received either salmeterol 50 μg or placebo twice daily from a Diskus inhaler for 12 months. The primary outcome was the number of moderate and severe exacerbations. Results: The median rate of ...

Asthma inhalers are a vital tool to help manage the common lung condition, but medics have warned that some users of blue inhalers are not using them correctly. Blue inhalers, also known as ...

Patients are advised to continue using their daily preventer inhaler as prescribed, and to speak to a healthcare professional if they find themselves needing their blue inhaler more than twice a week.